Gilead Sciences Inc
(BSP:GILD34)
R$
173.25
0 (0%)
Market Cap: 431.69 Bil
Enterprise Value: 540.80 Bil
PE Ratio: 180.72
PB Ratio: 4.63
GF Score: 78/100 - Q1 2024 Gilead Sciences Inc Earnings Call TranscriptApr 25, 2024R$174.25 (+0.72%)Earnings
- Gilead Sciences Inc at Barclays Global Healthcare Conference TranscriptMar 13, 2024
- Gilead Sciences Inc at Leerink Partners Global Biopharma Conference TranscriptMar 12, 2024
- Gilead Sciences Inc at TD Cowen Health Care Conference TranscriptMar 05, 2024
- Q4 2023 Gilead Sciences Inc Earnings Call TranscriptFeb 06, 2024R$191.7Earnings
- Gilead Sciences Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Gilead Sciences Inc at Piper Sandler Healthcare Conference TranscriptNov 29, 2023
- Gilead Sciences Inc at Evercore ISI HealthCONx Conference TranscriptNov 28, 2023
- Gilead Sciences Inc at Jefferies London Healthcare Conference TranscriptNov 15, 2023
- Q3 2023 Gilead Sciences Inc Earnings Call TranscriptNov 07, 2023R$201.6Earnings
- Assembly Biosciences Inc Partnership with Gilead Sciences Inc to Develop Next-Generation Antiviral Therapeutics Call TranscriptOct 17, 2023
- Gilead Sciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Gilead Sciences Inc at Wells Fargo Healthcare Conference TranscriptSep 06, 2023
- Q2 2023 Gilead Sciences Inc Earnings Call TranscriptAug 03, 2023R$184.44 (+0.77%)Earnings
- Gilead Sciences Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Gilead Sciences Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Gilead Sciences Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 16, 2023
- Gilead Sciences Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Gilead Sciences Inc Earnings Call TranscriptApr 27, 2023R$211.65Earnings
- Gilead Sciences Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Gilead Sciences Inc at Cowen Health Care Conference TranscriptMar 07, 2023
- Gilead Sciences Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 14, 2023
- Q4 2022 Gilead Sciences Inc Earnings Call TranscriptFeb 02, 2023R$202.24 (-4.41%)Earnings
- Gilead Sciences Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Gilead Sciences Inc and Arcus Biosciences Inc Post ARC-7 Plenary Q&A TranscriptDec 20, 2022
- Gilead Sciences Inc at Nasdaq Investor Conference TranscriptDec 07, 2022
- Gilead Sciences Inc at Piper Sandler Healthcare Conference TranscriptNov 30, 2022
- Gilead Sciences Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Q3 2022 Gilead Sciences Inc Earnings Call TranscriptOct 27, 2022R$184.48Earnings
- Gilead Sciences Inc at Robert W Baird Global Healthcare Conference TranscriptSep 14, 2022
- Gilead Sciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Gilead Sciences Inc at Wells Fargo Healthcare Conference TranscriptSep 08, 2022
- Q2 2022 Gilead Sciences Inc Earnings Call TranscriptAug 02, 2022R$156.15 (+0.44%)Earnings
- Gilead Sciences Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Gilead Sciences Inc at Jefferies Healthcare Conference TranscriptJun 08, 2022
- Gilead Sciences Inc at Sanford C Bernstein Strategic Decisions Conference TranscriptJun 02, 2022
- Gilead Sciences Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Gilead Sciences Inc Earnings Call TranscriptApr 28, 2022R$152.55 (-1.27%)Earnings
- Gilead Sciences Inc Oncology Deep Dive TranscriptApr 14, 2022
- Gilead Sciences Inc at Cowen Health Care Conference (Virtual) TranscriptMar 09, 2022
- Gilead Sciences Inc at Raymond James Institutional Investors Conference TranscriptMar 08, 2022
- Gilead Sciences Inc at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 16, 2022
- Q4 2021 Gilead Sciences Inc Earnings Call TranscriptFeb 01, 2022R$179.39 (-1.56%)Earnings
- Gilead Sciences Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2022
- Gilead Sciences Inc at Evercore ISI HealthCONx Virtual Conference TranscriptDec 02, 2021
- Arcus Biosciences to Discuss the Expanded Partnership with Gilead Sciences Inc- Conference Call TranscriptNov 18, 2021
- Q3 2021 Gilead Sciences Inc Earnings Call TranscriptOct 28, 2021R$189.48 (+1.75%)Earnings
- Gilead Sciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Q2 2021 Gilead Sciences Inc Earnings Call TranscriptJul 29, 2021R$177.17Earnings
- Gilead Sciences Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Gilead Sciences Inc at Sanford C Bernstein Strategic Decisions Conference (Virtual) TranscriptJun 02, 2021
- Gilead Sciences Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- Gilead Sciences Inc at Cowen Virtual Oncology Innovation Summit TranscriptMay 21, 2021
- Gilead Sciences Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- Gilead Sciences Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Gilead Sciences Inc Annual Shareholders Meeting TranscriptMay 12, 2021
- Q1 2021 Gilead Sciences Inc Earnings Call TranscriptApr 29, 2021R$171.48 (-1.33%)Earnings
- Merck & Co to Discuss Broad HIV Development Program and Newly Announced Collaboration with Gilead Sciences Inc - Conference Call TranscriptMar 15, 2021
- Gilead Sciences Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 04, 2021
- Gilead Sciences Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- Q4 2020 Gilead Sciences Inc Earnings Call TranscriptFeb 04, 2021R$178.05 (+2.01%)Earnings
- Gilead Sciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Galapagos NV & Gilead Sciences Inc to Announce New Commercialization and Development Agreement for Rheumatoid Arthritis Treatment Call TranscriptDec 16, 2020
- Gilead Sciences Inc at Evercore ISI HealthCONx Conference TranscriptDec 02, 2020
- Q3 2020 Gilead Sciences Inc Earnings Call TranscriptOct 28, 2020R$169.2 (+0.02%)Earnings
- Gilead Sciences Inc to Acquire Immunomedics Inc Conference Call TranscriptSep 13, 2020
- Q2 2020 Gilead Sciences Inc Earnings Call TranscriptJul 30, 2020R$185.9 (-2.26%)Earnings
- Gilead Sciences Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 04, 2020
- Gilead Sciences Inc Annual Shareholders Meeting TranscriptMay 06, 2020
- Q1 2020 Gilead Sciences Inc Earnings Call TranscriptApr 30, 2020R$225.6 (-0.53%)Earnings
- Gilead Sciences Inc at Cowen HealthCare Conference TranscriptMar 02, 2020
- Gilead Sciences Inc to Acquire Forty Seven Inc - Conference Call TranscriptMar 02, 2020
- Q4 2019 Gilead Sciences Inc Earnings Call TranscriptFeb 04, 2020R$142.29Earnings
- Gilead Sciences Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Gilead Sciences Inc Earnings Call TranscriptOct 24, 2019R$135.47Earnings
- Gilead Sciences Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Q2 2019 Gilead Sciences Inc Earnings Call TranscriptJul 30, 2019R$128.35Earnings
- Gilead Sciences Inc and Galapagos NV Enter Into Transformative Research and Development Collaboration Call TranscriptJul 14, 2019
- Gilead Sciences Inc at Jefferies Healthcare Conference TranscriptJun 05, 2019
- Gilead Sciences Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Gilead Sciences Inc Annual Shareholders Meeting TranscriptMay 08, 2019
- Q1 2019 Gilead Sciences Inc Earnings Call TranscriptMay 02, 2019R$128.25 (+0.45%)Earnings
- Gilead Sciences Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q4 2018 Gilead Sciences Inc Earnings Call TranscriptFeb 04, 2019Earnings
Gilead Sciences Inc at Cowen Health Care Conference (Virtual) Transcript
Mar 09, 2022 / 03:30PM GMT
Release Date Price:
R$147.81
(-1.69%)
Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - Analyst
Good morning, everyone. Welcome to the third day of Cowen's 42nd Annual Healthcare Conference. My name is Tyler Van Buren. I'm a senior biotech analyst here at Cowen. For this next session, we have a fireside chat with Gilead. It's my pleasure to introduce Andy Dickinson, Gilead's Chief Financial Officer. Andy, thank you very much for joining us here. It's a privilege to have you.
Andrew D. Dickinson
Gilead Sciences, Inc. - Executive VP & CFO
Thanks for having me. I'm happy to be here. Appreciate the invitation.
Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - Analyst
Right. Before we get started, I want to mention to the audience that you can submit questions via the web portal or e-mail me at [email protected] and I'll do my best to get those answered.
Questions & Answers
Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - Analyst
So we
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)